Oblique Therapeutics

17 jul 2019

We are proud to have been recognised by StartUp City Magazine as one of the most promising European Biotech startups in 2019!

Press release Oblique Therapeutics has been recognized as one of the 15 most promising Biotech startups in Europe…

28 mar 2019

We would like to welcome our new international- as well as Scandinavian owners after closing this funding round.

07 mar 2019

Oblique Therapeutics has entered into a collaboration agreement with a mid-sized Pharma for the development of the TRPV1…

10 jan 2019

Oblique Therapeutics were represented at J.P. Morgan in San Fransisco by Jessica Hägglund, senior researcher, Owe Orwar, CEO,…

01 Nov 2018

Our CEO, Owe Orwar, and CSO, Carolina Trkulja, will be attending BioEurope in Copenhagen, 5-7 November, 2018